About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 759626, 8 pages
http://dx.doi.org/10.1155/2012/759626
Review Article

Oral Lichen Planus as a Preneoplastic Inflammatory Model

1Department of Histology and Embryology, Faculty of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Goudi, 11527 Athens, Greece
2Department of Anatomy, Faculty of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
3Dental Clinic, General Hospital Paidon Pentelis, Ippokratous 8, Penteli, 15236 Athens, Greece
4Major (Hellenic Army) D'Army Corps, Biopathologist Stuff Officer, Thermopilon 01, 67100 Xanthi, Greece
52nd Department of Pathology, Faculty of Medicine, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece

Received 12 January 2012; Accepted 16 March 2012

Academic Editor: Vassilis Gorgoulis

Copyright © 2012 Eleni A. Georgakopoulou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Scully and M. Carrozzo, “Oral mucosal disease: lichen planus,” British Journal of Oral and Maxillofacial Surgery, vol. 46, no. 1, pp. 15–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Bidarra, J. A. G. Buchanan, C. Scully, D. R. Moles, and S. R. Porter, “Oral lichen planus: a condition with more persistence and extra-oral involvement than suspected?” Journal of Oral Pathology and Medicine, vol. 37, no. 10, pp. 582–586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Carrozzo, “How common is oral lichen planus?” Evidence-Based Dentistry, vol. 9, no. 4, pp. 112–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Gonzalez-Moles, C. Scully, and J. A. Gil-Montoya, “Oral lichen planus: controversies surrounding malignant transformation,” Oral Diseases, vol. 14, no. 3, pp. 229–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Lodi, C. Scully, M. Carrozzo, et al., “Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 100, no. 2, pp. 164–178, 2005.
  6. E. H. Van der Meij and I. Van der Waal, “Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications,” Journal of Oral Pathology and Medicine, vol. 32, no. 9, pp. 507–512, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. V. Dorrego, M. Correnti, R. Delgado, and F. J. Tapia, “Oral lichen planus: immunohistology of mucosal lesions,” Journal of Oral Pathology and Medicine, vol. 31, no. 7, pp. 410–414, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. P. B. Sugerman, N. W. Savage, L. J. Walsh et al., “The pathogenesis of oral lichen planus,” Critical Reviews in Oral Biology and Medicine, vol. 13, no. 4, pp. 350–365, 2002. View at Scopus
  9. D. Farhi and N. Dupin, “Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies,” Clinics in Dermatology, vol. 28, no. 1, pp. 100–108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Lodi, C. Scully, M. Carrozzo, et al., “Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 100, no. 1, pp. 40–51, 2005.
  11. S. Warnakulasuriya, N. W. Johnson, and I. Van Der Waal, “Nomenclature and classification of potentially malignant disorders of the oral mucosa,” Journal of Oral Pathology and Medicine, vol. 36, no. 10, pp. 575–580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. V. Keenan and D. Ferraiolo, “Insufficient evidence for effectiveness of any treatment for oral lichen planus,” Evidence-Based Dentistry, vol. 12, no. 3, pp. 85–86, 2011.
  13. N. A. Barnard, C. Scully, J. W. Eveson, S. Cunningham, and S. R. Porter, “Oral cancer development in patients with oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 22, no. 9, pp. 421–424, 1993. View at Scopus
  14. M. D. Mignogna, S. Fedele, L. Lo Russo, L. Lo Muzio, and E. Bucci, “Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence?” Oral Oncology, vol. 40, no. 2, pp. 120–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Battino, M. Greabu, A. Totan et al., “Oxidative stress markers in oral lichen planus,” BioFactors, vol. 33, no. 4, pp. 301–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kawanishi, Y. Hiraku, S. Pinlaor, and N. Ma, “Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis,” Biological Chemistry, vol. 387, no. 4, pp. 365–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ergun, Ş. C. Troşala, S. Warnakulasuriya et al., “Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 40, no. 4, pp. 286–293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Liu, D. V. Messadi, H. Wu, and S. Hu, “Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer,” Medical Hypotheses, vol. 75, no. 6, pp. 492–494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Mattila and S. Syrjanen, “Caspase cascade pathways in apoptosis of oral lichen planus,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 110, no. 5, pp. 618–623, 2010.
  20. E. Neppelberg, A. C. Johannessen, and R. Jonsson, “Apoptosis in oral lichen planus,” European Journal of Oral Sciences, vol. 109, no. 5, pp. 361–364, 2001. View at Scopus
  21. A. Karatsaidis, K. Hayashi, O. Schreurs, K. Helgeland, and K. Schenck, “Survival signalling in keratinocytes of erythematous oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 36, no. 4, pp. 215–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Taniguchi, T. Nagao, H. Maeda, Y. Kameyama, and K. A. A. S. Warnakulasuriya, “Epithelial cell proliferation in oral lichen planus,” Cell Proliferation, vol. 35, no. 1, pp. 103–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Ó. Flatharta, S. Flint, M. Toner, and M. Mabruk, “hTR RNA component as a marker of cellular proliferation in oral lichen planus,” Asian Pacific Journal of Cancer Prevention, vol. 9, no. 2, pp. 287–290, 2008. View at Scopus
  24. F. A. Sousa, T. C. Paradella, Y. R. Carvalho, and L. E. Rosa, “Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia,” Journal of Oral Science, vol. 51, no. 1, pp. 117–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Hirota, T. Ito, K. Okudela et al., “Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 31, no. 4, pp. 204–212, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. S. I. Tobón-Arroyave, F. A. Villegas-Acosta, S. M. Ruiz-Restrepo, B. Vieco-Durán, M. Restrepo-Misas, and M. L. Londoño-López, “Expression of caspase-3 and structural changes associated with apoptotic cell death of keratinocytes in oral lichen planus,” Oral Diseases, vol. 10, no. 3, pp. 173–178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Mattila, K. Alanen, and S. Syrjanen, “Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions,” Archives of Dermatological Research, vol. 298, no. 8, pp. 381–388, 2007.
  28. M. A. González-Moles, C. Bascones-Ilundain, J. A. Gil Montoya, I. Ruiz-Avila, M. Delgado-Rodríguez, and A. Bascones-Martínez, “Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation,” Archives of Oral Biology, vol. 51, no. 12, pp. 1093–1103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Bascones-Ilundain, M. A. Gonzalez-Moles, G. Esparza, J. A. Gil-Montoya, and A. Bascones-Martinez, “Significance of liquefaction degeneration in oral lichen planus: a study of its relationship with apoptosis and cell cycle arrest markers,” Clinical and Experimental Dermatology, vol. 32, no. 5, pp. 556–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Bascones, M. A. Gonzalez-Moles, G. Esparza et al., “Apoptosis and cell cycle arrest in oral lichen planus: hypothesis on their possible influence on its malignant transformation,” Archives of Oral Biology, vol. 50, no. 10, pp. 873–881, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Gonzalez-Moles, J. A. Gil-Montoya, I. Ruiz-Avila, F. Esteban, and A. Bascones-Martinez, “Differences in the expression of p53 protein in oral lichen planus based on the use of monoclonal antibodies DO7 and pAb 240,” Oral Oncology, vol. 44, no. 5, pp. 496–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9363–9367, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Poomsawat, W. Buajeeb, S. O. P. Khovidhunkit, and J. Punyasingh, “Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy,” Journal of Oral Pathology and Medicine, vol. 40, no. 4, pp. 294–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Montebugnoli, M. Venturi, D. B. Gissi, et al., “Immunohistochemical expression of p16(INK4A) protein in oral lichen planus,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 112, no. 2, pp. 222–227, 2011.
  35. M. Gasco and T. Crook, “The p53 network in head and neck cancer,” Oral Oncology, vol. 39, no. 3, pp. 222–231, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Ebrahimi, K. Nylander, and I. van der Waal, “Oral lichen planus and the p53 family: what do we know?” Journal of Oral Pathology and Medicine, vol. 40, no. 4, pp. 281–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. D. W. Meek, “The p53 response to DNA damage,” DNA Repair, vol. 3, no. 8-9, pp. 1049–1056, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Safadi, S. Z. A. Jaber, H. M. Hammad, and A. A. H. Hamasha, “Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study,” Archives of Oral Biology, vol. 55, no. 6, pp. 454–461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Chaiyarit, N. Ma, Y. Hiraku et al., “Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis,” Cancer Science, vol. 96, no. 9, pp. 553–559, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. Lee, M. Y. Kuo, S. J. Cheng, et al., “Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 99, no. 4, pp. 471–478, 2005.
  41. J. Bartkova, N. Rezaei, M. Liontos et al., “Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints,” Nature, vol. 444, no. 7119, pp. 633–637, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. V. G. Gorgoulis, L. V. F. Vassiliou, P. Karakaidos et al., “Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions,” Nature, vol. 434, no. 7035, pp. 907–913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Zhang, C. Michelsen, X. Cheng, T. Zeng, R. Priddy, and M. P. Rosin, “Molecular analysis of oral lichen planus: a premalignant lesion?” American Journal of Pathology, vol. 151, no. 2, pp. 323–327, 1997. View at Scopus
  44. L. Zhang, X. Cheng, Y. H. Li et al., “High frequency of allelic loss in dysplastic lichenoid lesions,” Laboratory Investigation, vol. 80, no. 2, pp. 233–237, 2000. View at Scopus
  45. J. Kim, J. I. Yook, E. H. Lee et al., “Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics,” Journal of Oral Pathology and Medicine, vol. 30, no. 2, pp. 65–72, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. B. T. Accurso, B. M. Warner, T. J. Knobloch, et al., “Allelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 112, no. 3, pp. 359–366, 2011.
  47. F. Femiano and C. Scully, “DNA cytometry of oral leukoplakia and oral lichen planus,” Medicina Oral Patologia Oral y Cirugia Bucal, vol. 10, supplement 1, pp. E9–E14, 2005. View at Scopus
  48. E. S. Hosni, L. S. Yurgel, and V. D. D. Silva, “DNA ploidy in oral lichen planus, determined by image cytometry,” Journal of Oral Pathology and Medicine, vol. 39, no. 3, pp. 206–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Rode, M. S. Flezar, M. Kogoj-Rode, et al., “Image cytometric evaluation of nuclear texture features and DNA content of the reticular form of oral lichen planus,” Analytical & Quantitative Cytology & Histology, vol. 28, no. 5, pp. 262–268, 2006.
  50. L. Montebugnoli, A. Farnedi, C. Marchetti, E. Magrini, A. Pession, and M. P. Foschini, “High proliferative activity and chromosomal instability in oral lichen planus,” International Journal of Oral and Maxillofacial Surgery, vol. 35, no. 12, pp. 1140–1144, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Sutinen, T. Kainulainen, T. Hurskainen et al., “Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis,” British Journal of Cancer, vol. 77, no. 12, pp. 2239–2245, 1998. View at Scopus
  52. X. J. Zhou, P. B. Sugerman, N. W. Savage, and L. J. Walsh, “Matrix metalloproteinases and their inhibitors in oral lichen planus,” Journal of Cutaneous Pathology, vol. 28, no. 2, pp. 72–82, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Mazzarella, F. Femiano, F. Gombos, A. De Rosa, and M. Giuliano, “Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular forms,” Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 8, pp. 953–957, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. S. G. Kim, C. H. Chae, B. O. Cho et al., “Apoptosis of oral epithelial cells in oral lichen planus caused by upregulation of BMP-4,” Journal of Oral Pathology and Medicine, vol. 35, no. 1, pp. 37–45, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Chen, W. Zhang, N. Geng, K. Tian, and L. J. Windsor, “MMPs, TIMP-2, AND TGF-β1 in the cancerization of oral lichen planus,” Head and Neck, vol. 30, no. 9, pp. 1237–1245, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. L. L. Tsai, S. F. Yang, C. H. Tsai, M. Y. Chou, and Y. C. Chang, “Concomitant upregulation of matrix metalloproteinase-2 in lesions and circulating plasma of oral lichen planus,” Journal of Dental Sciences, vol. 4, no. 1, pp. 7–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Karin, “NF-kappaB as a critical link between inflammation and cancer,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 5, p. a000141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Santoro, A. Majorana, E. Bardellini, S. Festa, P. Sapelli, and F. Facchetti, “NF-κB expression in oral and cutaneous lichen planus,” Journal of Pathology, vol. 201, no. 3, pp. 466–472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. N. L. Rhodus, B. Cheng, S. Myers, W. Bowles, V. Ho, and F. Ondrey, “A comparison of the pro-inflammatory, NF-κB-dependent cytokines: TNF-alpha, IL-1-alpha, IL-6, and IL-8 in different oral fluids from oral lichen planus patients,” Clinical Immunology, vol. 114, no. 3, pp. 278–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. N. L. Rhodus, B. Cheng, S. Myers, L. Miller, V. Ho, and F. Ondrey, “The feasibility of monitoring NF-κB associated cytokines: TNF-α, IL-1α, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus,” Molecular Carcinogenesis, vol. 44, no. 2, pp. 77–82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Zhang, M. Lin, S. Zhang et al., “NF-κB-dependent cytokines in saliva and serum from patients with oral lichen planus: a study in an ethnic Chinese population,” Cytokine, vol. 41, no. 2, pp. 144–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Sethi, B. Sung, and B. B. Aggarwal, “TNF: a master switch for inflammation to cancer,” Frontiers in Bioscience, vol. 13, no. 13, pp. 5094–5107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. P. B. Sugermann, N. W. Savage, G. J. Seymour, and L. J. Walsh, “Is there a role for tumor necrosis factor-alpha (TNF-α) in oral lichen planus?” Journal of Oral Pathology and Medicine, vol. 25, no. 5, pp. 219–224, 1996. View at Scopus
  64. M. Carrozzo, M. U. De Capei, E. Dametto et al., “Tumor necrosis factor-α and interferon-γ polymorphisms contribute to susceptibility to oral lichen planus,” Journal of Investigative Dermatology, vol. 122, no. 1, pp. 87–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Bai, L. Jiang, M. Lin, X. Zeng, Z. Wang, and Q. Chen, “Association of polymorphisms in the tumor necrosis factor-α and interleukin-10 genes with oral lichen planus: a study in a Chinese cohort with Han ethnicity,” Journal of Interferon and Cytokine Research, vol. 29, no. 7, pp. 381–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. I. Kimkong, N. Hirankarn, J. Nakkuntod, and N. Kitkumthorn, “Tumour necrosis factor-alpha gene polymorphisms and susceptibility to oral lichen planus,” Oral Diseases, vol. 17, no. 2, pp. 206–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. G. M. Xavier, A. R. D. Sá, A. L. S. Guimarães, T. A. D. Silva, and R. S. Gomez, “Investigation of functional gene polymorphisms interleukin-1β, interleukin-6, interleukin-10 and tumor necrosis factor in individuals with oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 36, no. 8, pp. 476–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Sklavounou-Andrikopoulou, E. Chrysomali, M. Iakovou, G. A. Garinis, and A. Karameris, “Elevated serum levels of the apoptosis related molecules TNF-α, Fas/Apo-1 and Bcl-2 in oral lichen planus,” Journal of Oral Pathology and Medicine, vol. 33, no. 7, pp. 386–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Pezelj-Ribaric, I. B. Prso, M. Abram, I. Glazar, G. Brumini, and M. Simunovic-Soskic, “Salivary levels of tumor necrosis factor-α in oral lichen planus,” Mediators of Inflammation, vol. 13, no. 2, pp. 131–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. N. L. Rhodus, B. Cheng, W. Bowles, S. Myers, L. Miller, and F. Ondrey, “Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone,” Oral Diseases, vol. 12, no. 2, pp. 112–116, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. N. A. Ghallab, N. El-Wakeel, and O. G. Shaker, “Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (Erosive) oral lichen planus,” Mediators of Inflammation, vol. 2010, Article ID 847632, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Thongprasom, K. Dhanuthai, W. Sarideechaigul, P. Chaiyarit, and M. Chaimusig, “Expression of TNF-α in oral lichen planus treated with fluocinolone acetonide 0.1%,” Journal of Oral Pathology and Medicine, vol. 35, no. 3, pp. 161–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Sklavounou, E. Chrysomali, A. Scorilas, and A. Karameris, “TNF-α expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation,” Journal of Oral Pathology and Medicine, vol. 29, no. 8, pp. 370–375, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. T. J. Chao, “Adalimumab in the management of cutaneous and oral Lichen planus,” Cutis, vol. 84, no. 6, pp. 325–328, 2009. View at Scopus
  75. N. Yarom, “Etanercept for the management of oral lichen planus,” American Journal of Clinical Dermatology, vol. 8, no. 2, p. 121, 2007. View at Scopus
  76. G. M. Gu, M. D. Martin, R. P. Darveau, et al., “Oral and serum IL-6 levels in oral lichen planus patients,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 98, no. 6, pp. 673–678, 2004.
  77. N. L. Rhodus, B. Cheng, and F. Ondrey, “Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus,” Mediators of Inflammation, vol. 2007, Article ID 19854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Kalogerakou, E. Albanidou-Farmaki, A. K. Markopoulos, and D. Z. Antoniades, “Detection of T cells secreting type 1 and type 2 cytokines in the peripheral blood of patients with oral lichen planus,” Hippokratia, vol. 12, no. 4, pp. 230–235, 2008. View at Scopus
  79. S. Matsumoto, T. Hara, K. Mitsuyama et al., “Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model,” Journal of Immunology, vol. 184, no. 3, pp. 1543–1551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Rose-John, J. Scheller, G. Elson, and S. A. Jones, “Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer,” Journal of Leukocyte Biology, vol. 80, no. 2, pp. 227–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Bhaumik, G. K. Scott, S. Schokrpur et al., “MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8,” Aging, vol. 1, no. 4, pp. 402–411, 2009. View at Scopus
  82. M. Carrozzo, “Oral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases,” Oral Diseases, vol. 14, no. 3, pp. 217–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Kumar, “MicroRNA in HCV infection and liver cancer,” Biochimica et Biophysica Acta, vol. 1809, no. 11-12, pp. 694–699, 2011.
  84. A. P. J. Vlaar, S. T. Rietdijk, S. S. Zeerleder, T. Boerman, and U. Beuers, “Malignancies associated with chronic hepatitis C: case report and review of the literature,” Netherlands Journal of Medicine, vol. 69, no. 5, pp. 211–215, 2011. View at Scopus
  85. G. Lodi, I. Olsen, A. Piattelli, E. D'Amico, L. Artese, and S. R. Porter, “Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection,” Journal of Oral Pathology and Medicine, vol. 26, no. 1, pp. 36–39, 1997. View at Scopus
  86. F. Femiano and C. Scully, “Functions of the cytokines in relation oral lichen planus-hepatitis C,” Medicina Oral Patologia Oral y Cirugia Bucal, vol. 10, pp. E40–E44, 2005. View at Scopus
  87. Y. Nagao, M. Sata, S. Noguchi et al., “Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues,” Journal of Oral Pathology and Medicine, vol. 29, no. 6, pp. 259–266, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. M. A. Jaber, S. R. Porter, L. Bain, and C. Scully, “Lack of association between hepatitis C virus and oral epithelial dysplasia in British patients,” International Journal of Oral and Maxillofacial Surgery, vol. 32, no. 2, pp. 181–183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. M. G. O. Alves, J. D. Almeida, and L. A. G. Cabral, “Association between hepatitis C virus and oral lichen planus,” Hepatitis Monthly, vol. 11, no. 2, pp. 132–133, 2011. View at Scopus
  90. C. Canavan, K. R. Abrams, and J. Mayberry, “Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease,” Alimentary Pharmacology and Therapeutics, vol. 23, no. 8, pp. 1097–1104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. C. N. Bernstein, J. F. Blanchard, E. Kliewer, et al., “Cancer risk in patients with inflammatory bowel disease: a population-based study,” Cancer, vol. 91, no. 4, pp. 854–862, 2001.
  92. P. M. Choi and M. P. Zelig, “Similarity of colorectal cancer of Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention,” Gut, vol. 35, no. 7, pp. 950–954, 1994. View at Scopus
  93. S. Fedele, L. Lo Russo, C. Mignogna, S. Staibano, S. R. Porter, and M. D. Mignogna, “Macroscopic classification of superficial neoplastic lesions of the oral mucosa: a preliminary study,” European Journal of Surgical Oncology, vol. 34, no. 1, pp. 100–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. M. D. Mignogna, L. Lo Russo, S. Fedele, E. Ruoppo, L. Califano, and L. Lo Muzio, “Clinical behaviour of malignant transforming oral lichen planus,” European Journal of Surgical Oncology, vol. 28, no. 8, pp. 838–843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. J. E. Sigel, R. E. Petras, B. A. Lashner, V. W. Fazio, and J. R. Goldblum, “Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia,” American Journal of Surgical Pathology, vol. 23, no. 6, pp. 651–655, 1999. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Veltkamp, M. Anstaett, K. Wahl et al., “Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment,” Gut, vol. 60, no. 10, pp. 1345–1353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. E. K. Boden and S. B. Snapper, “Regulatory T cells in inflammatory bowel disease,” Current Opinion in Gastroenterology, vol. 24, no. 6, pp. 733–741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. C. M. Aherne, C. B. Collins, J. C. Masterson et al., “Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis,” Gut, vol. 61, no. 5, pp. 733–741, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Paradisi, C. Maisse, M. M. Coissieux et al., “Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 40, pp. 17146–17151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Paradisi, C. Maisse, A. Bernet et al., “NF-κB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors,” Gastroenterology, vol. 135, no. 4, pp. 1248–1257, 2008. View at Publisher · View at Google Scholar · View at Scopus